Schreitmüller T, Hochstrasser K, Reisinger P W, Wachter E, Gebhard W
Abteilung für Klinische Chemie und Klinische Biochemie in der Chirurgischen Klinik Innenstadt der Universität München.
Biol Chem Hoppe Seyler. 1987 Aug;368(8):963-70. doi: 10.1515/bchm3.1987.368.2.963.
Inter-alpha-trypsin inhibitor (ITI) is a serum protein of unknown function. Part of the molecule (formerly called HI30) is closely related to a tumor-derived protein acting as a growth factor for endothelial cells. We screened a human liver cDNA expression library with antibodies raised against human ITI and isolated several clones which could be divided into three groups according to their DNA sequences. The cDNA of the first group codes for a protein composed of alpha 1-microglobulin (alpha 1M) and urinary trypsin inhibitor (UTI) and is identical to that encoded by a clone originally found by screening a human liver cDNA library with oligonucleotides derived from amino-acid sequences of the two Kunitz-type domains of UTI. The proteins derived from the cDNA of the second and the third group of clones are distantly related to each other, but unrelated to the protein derived from group 1 clones. Partial amino-acid sequencing of ITI isolated from serum allowed the verification of large parts of the cDNA-derived amino-acid sequences. The results favour the view that ITI is not a single chain protein, but rather a very tight complex of several components or a mixture of such complexes.
α-胰蛋白酶抑制剂(ITI)是一种功能未知的血清蛋白。该分子的一部分(以前称为HI30)与一种肿瘤衍生蛋白密切相关,该肿瘤衍生蛋白可作为内皮细胞的生长因子。我们用针对人ITI产生的抗体筛选了人肝脏cDNA表达文库,并分离出几个克隆,根据其DNA序列可将这些克隆分为三组。第一组的cDNA编码一种由α1-微球蛋白(α1M)和尿胰蛋白酶抑制剂(UTI)组成的蛋白质,与最初通过用源自UTI两个Kunitz型结构域氨基酸序列的寡核苷酸筛选人肝脏cDNA文库而发现的一个克隆所编码的蛋白质相同。第二组和第三组克隆的cDNA衍生的蛋白质彼此关系较远,但与第一组克隆衍生的蛋白质无关。对从血清中分离出的ITI进行部分氨基酸测序,使得能够验证cDNA衍生的氨基酸序列的大部分。结果支持这样一种观点,即ITI不是单链蛋白,而是几种成分的非常紧密的复合物或此类复合物的混合物。